Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marie-Line Goulet
Observed names:
Goulet, Marie-Line,
M-L Goulet,
M-l Goulet,
M.-L. Goulet,
M.L. Goulet,
Marie-line Goulet,
Marieline Goulet
show all 7
Observed institutions:
University of Ottawa,
Jewish General Hospital,
Montreal Clinical Research Institute,
Lady Davis Institute for Medical Research,
McGill University,
Université de Montréal
show all 6
OpenAlex ID:
A5073790205
Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus Infectivity
2013
·
Marie-Line Goulet
, David Olagnier
, et al.
·
PLoS Pathogens
·
121
PDF
Linear Ubiquitination of NEMO Negatively Regulates the Interferon Antiviral Response through Disruption of the MAVS-TRAF3 Complex
2012
·
S. Mehdi Belgnaoui
, Suzanne Paz
, et al.
·
Cell Host & Microbe
·
119
PDF
Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists
2015
·
Cindy Chiang
, Vladimir Beljanski
, et al.
·
Journal of Virology
·
88
RIG-I-Mediated STING Upregulation Restricts Herpes Simplex Virus 1 Infection
2016
·
Yiliu Liu
, Marie-Line Goulet
, et al.
·
Journal of Virology
·
85
Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity
2017
·
David Olagnier
, Rassin R. Lababidi
, et al.
·
Molecular Therapy
·
78
PDF
Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC
2008
·
Lee-Hwa Tai
, Marie-Line Goulet
, et al.
·
The Journal of Experimental Medicine
·
62
PDF
STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer
2021
·
Stephanie P. Totten
, Young Kyuen Im
, et al.
·
Nature Communications
·
60
PDF
Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes
2005
·
A P Makrigiannis
, D Patel
, et al.
·
Genes and Immunity
·
55
Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype
2005
·
S K Anderson
, K Dewar
, et al.
·
Genes and Immunity
·
52
Vesicular Stomatitis Virus Oncolytic Treatment Interferes with Tumor-Associated Dendritic Cell Functions and Abrogates Tumor Antigen Presentation
2011
·
Simon Leveille
, Marie-Line Goulet
, et al.
·
Journal of Virology
·
48
Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy
2011
·
S Leveille
, S Samuel
, et al.
·
Cancer Gene Therapy
·
48
Caspase-12 Dampens the Immune Response to Malaria Independently of the Inflammasome by Targeting NF-κB Signaling
2010
·
Katherine Labbé
, Jenny Miu
, et al.
·
The Journal of Immunology
·
45
Triptolide-Mediated Inhibition of Interferon Signaling Enhances Vesicular Stomatitis Virus-Based Oncolysis
2013
·
Fethia Ben Yebdri
, Julien Van Grevenynghe
, et al.
·
Molecular Therapy
·
29
PDF
BCL-2 Inhibitors Sensitize Therapy-resistant Chronic Lymphocytic Leukemia Cells to VSV Oncolysis
2013
·
Sara Samuel
, Vladimir Beljanski
, et al.
·
Molecular Therapy
·
29
Correction: Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus Infectivity
2013
·
Marie-Line Goulet
, David Olagnier
, et al.
·
PLoS Pathogens
·
26
PDF
Recognition of H-2Kb by Ly49Q suggests a role for class Ia MHC regulation of plasmacytoid dendritic cell function
2007
·
Lee-Hwa Tai
, Marie-Line Goulet
, et al.
·
Molecular Immunology
·
23
Ly49Q Positively Regulates Type I IFN Production by Plasmacytoid Dendritic Cells in an Immunoreceptor Tyrosine–Based Inhibitory Motif–Dependent Manner
2013
·
Mir Munir A Rahim
, Lee-Hwa Tai
, et al.
·
The Journal of Immunology
·
22
Abstract PR006: EG-70 (detalimogene voraplasmid), a novel, non-viral intravesical gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: Preclinical characterization and translation into the clinic
2024
·
Marie-Line Goulet
, Shauna M Dauphinee
, et al.
·
Clinical Cancer Research
·
1
Mechanism of Action and Translation to the Clinic of Detalimogene Voraplasmid (eg-70) – a Novel, Investigational Non-viral Immunotherapy for Non-muscle-invasive Bladder Cancer
2025
·
James C. Sullivan
, Yair Lotan
, et al.
·
Urologic Oncology Seminars and Original Investigations
Mechanism of action and translation to the clinic of detalimogene voraplasmid (EG-70): A novel, investigational, non-viral immunotherapy for non-muscle-invasive bladder cancer (NMIBC).
2025
·
Vikram M. Narayan
, Yair Lotan
, et al.
·
Journal of Clinical Oncology
993 Mechanism of action and translation to the clinic of EG-70 – a novel, investigational non-viral immunotherapy for non-muscle-invasive bladder cancer
2024
·
Jim Sullivan
, Marie-Line Goulet
, et al.
·
Journal for ImmunoTherapy of Cancer
456 (PB444): EG-70 (detalimogene voraplasmid), a novel, investigational non-viral immunotherapy for non-muscle-invasive bladder cancer: mechanism of action and translation to the clinic
2024
·
J. Sullivan
, M.L. Goulet
, et al.
·
European Journal of Cancer
ID: 113
2015
·
Rongtuan Lin
, Yiliu Liu
, et al.
·
Cytokine
116
2014
·
Yiliu Liu
, Sidi Mehdi Belgnaoui
, et al.
·
Cytokine
289
2013
·
Fethia Ben Yebdri
, Julien VanGrevenynghe
, et al.
·
Cytokine
Show more works
View as search
Works count:
33
Citation count:
991
H-index:
17
I10-index:
17
Year
Topic
Type
